Yvette Bordelon is a Neurology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 142 publications with 8,061 citations (h-index 42).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
127 S San Vicente Blvd Ste A6600
Los Angeles, CA 900483311
Telephone
310-423-6472Provider last certified this registry record 14 Nov 2023.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20252 payments
- Boston Scientific CorporationProgram year20255 payments
- Medtronic, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92.7%Aromatic Amino Acid Decarboxylation Inhibitor33%Carbidopa-Levodopa54%Rytary22%Carbidopa-Levodopa Er17%Carbidopa-Levodopa-Entacapone8%Part D<11 patientsCholinesterase Inhibitor10.1%Donepezil Hcl100%Part D≥47 patients+ 15 more classes in this area
Cardiovascular
3.6%Beta blocker2.9%Propranolol Hcl51%Propranolol Hcl Er49%Part D<11 patientsalpha-Adrenergic Agonist0.7%Midodrine Hcl100%Part D<11 patientsMusculoskeletal
1.2%gamma-Aminobutyric Acid-ergic Agonist1.2%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2008–2012 per NIH RePORTER. The latest:
- Identification of Biomarkers of Huntington Disease in Human and Rat
University of California Los Angeles
FY2012$158,596K23NS059743 - Identification of Biomarkers of Huntington Disease in Human and Rat
University of California Los Angeles
FY2011$162,207K23NS059743 - Identification of Biomarkers of Huntington Disease in Human and Rat
University of California Los Angeles
FY2010$164,160K23NS059743
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Beth Karlan, MD
Cedars-Sinai Medical Center
Raj Makkar, MD
Cedars-Sinai Medical Center
Paul Noble, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”